Walvax BioTech (300142)

Currency in CNY
12.37
+0.21(+1.73%)
Closed·
300142 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.1112.54
52 wk Range
9.7015.12
Key Statistics
Bid/Ask
12.37 / 12.37
Prev. Close
12.16
Open
12.22
Day's Range
12.11-12.54
52 wk Range
9.7-15.12
Volume
32.49M
Average Volume (3m)
34.91M
1-Year Change
-15.63%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300142 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.00
Downside
-43.41%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Walvax BioTech News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Walvax BioTech Company Profile

Walvax Biotechnology Co., Ltd., engages in the research and development, manufacture, and distribution of vaccines in China. Its vaccine portfolio includes recombinant human papillomavirus bivalent, 13-valent pneumococcal polysaccharide conjugate, 23-valent pneumococcal polysaccharide, group ACYW135 meningococcal polysaccharide, group A and C meningococcal polysaccharide, group A and group C meningococcal conjugate, and haemophilus influenzae type b conjugate vaccines, as well as diphtheria, tetanus and acellular pertussis combined vaccine. The company was founded in 2001 and is headquartered in Kunming, China.

Employees
2388
Market
China

Compare 300142 to Peers and Sector

Metrics to compare
300142
Peers
Sector
Relationship
P/E Ratio
402.1x42.2x−0.6x
PEG Ratio
−6.73−0.670.00
Price/Book
2.0x2.3x2.6x
Price / LTM Sales
8.3x6.7x3.3x
Upside (Analyst Target)
−43.5%24.1%41.2%
Fair Value Upside
Unlock2.2%4.8%Unlock

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Strong Sell

Analysts 12-Month Price Target:

Average 7.00
(-43.41% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.03%
Dividend Yield
0.08%
Industry Median 1.42%
Annualised payout
0.01
Paid unevenly
5-Years Growth
-12.94%
Growth Streak

Earnings

Latest Release
Oct 29, 2025
EPS / Forecast
0.08 / 0.09
Revenue / Forecast
564.60M / 904.01M
EPS Revisions
Last 90 days

300142 Income Statement

FAQ

What Stock Exchange Does Walvax BioTech Trade On?

Walvax BioTech is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Walvax BioTech?

The stock symbol for Walvax BioTech is "300142."

What Is the Walvax BioTech Market Cap?

As of today, Walvax BioTech market cap is 19.80B.

What Is Walvax BioTech's Earnings Per Share (TTM)?

The Walvax BioTech EPS (TTM) is 0.03.

When Is the Next Walvax BioTech Earnings Date?

Walvax BioTech will release its next earnings report on 22 Mar 2026.

From a Technical Analysis Perspective, Is 300142 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Walvax BioTech Stock Split?

Walvax BioTech has split 5 times.

How Many Employees Does Walvax BioTech Have?

Walvax BioTech has 2388 employees.

What is the current trading status of Walvax BioTech (300142)?

As of 25 Nov 2025, Walvax BioTech (300142) is trading at a price of 12.37, with a previous close of 12.16. The stock has fluctuated within a day range of 12.11 to 12.54, while its 52-week range spans from 9.70 to 15.12.

What Is Walvax BioTech (300142) Price Target According to Analysts?

The average 12-month price target for Walvax BioTech is CNY7, with a high estimate of CNY7 and a low estimate of CNY7. 0 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Sell. The stock has an -43.41% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.